Accueil / Tag Archives: California

Tag Archives: California

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis

Friday, July 19th 2019 at 12:30pm UTC FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global …

Plus »

Study Shows Spatial Biology Is Essential for Predicting Response to Immuno-Oncology Treatment

Thursday, July 18th 2019 at 3:27pm UTC In JAMA Oncology report, multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies MENLO PARK, Calif.–(BUSINESS WIRE)– Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker types conducted by scientists at Johns Hopkins University, …

Plus »

Study Shows Spatial Biology Is Essential for Predicting Response to Immuno-Oncology Treatment

Thursday, July 18th 2019 at 3:27pm UTC In JAMA Oncology report, multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies MENLO PARK, Calif.–(BUSINESS WIRE)– Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker types conducted by scientists at Johns Hopkins University, …

Plus »

Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors

Wednesday, July 17th 2019 at 12:00pm UTC – Nolet will serve as Chair of the Audit Committee – NEWARK, Calif.–(BUSINESS WIRE)– ?Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company developing a new category of high-performance neuromodulators for use in treating aesthetic and therapeutic conditions, today announced the appointment of Chris …

Plus »

ACADIA Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019

Wednesday, July 17th 2019 at 1:00pm UTC ACADIA to Host Conference Call and Webcast on Wednesday, July 31, 2019, at 4:30 p.m. Eastern Time SAN DIEGO–(BUSINESS WIRE)– ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in …

Plus »

Cortexyme’s Approach to Addressing a Key Underlying Cause of Alzheimer’s Detailed at Alzheimer’s Association International Conference 2019

Wednesday, July 17th 2019 at 3:00pm UTC — Rationale and design of the GAIN trial discussed in AAIC news briefing earlier this morning — In Phase 1b testing, COR388 was associated with reductions in markers of inflammation and pathological ApoE fragmentation SOUTH SAN FRANCISCO, Calif. & LOS ANGELES–(BUSINESS WIRE)– Cortexyme, …

Plus »

Seer Announces Appointment of Mark McClellan, MD, PhD to Board of Directors

Wednesday, July 17th 2019 at 1:01pm UTC -Completes additional $17.5 million financing round- -Advancing pipeline of first-in-class liquid biopsy products for early, pre-symptomatic detection of cancer and neurological diseases- -Recent platform advancements in speed, cost and protein coverage accelerating vision to provide proteomic information at scale- SOUTH SAN FRANCISCO, Calif.–(BUSINESS …

Plus »

Gilead to Present New Data on HIV Prevention, Treatment and Cure Research at IAS 2019

Thursday, July 18th 2019 at 12:30pm UTC FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) today announced that new data from the company’s HIV research and development programs will be presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City from …

Plus »

LifeMax Receives Rare Pediatric Disease Designation for LM-030 for the Treatment of Netherton Syndrome

Thursday, July 18th 2019 at 11:00am UTC PALO ALTO, Calif.–(BUSINESS WIRE)– LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating rare diseases with few or no therapeutic options, today announced that the Food & Drug Administration (FDA) granted rare pediatric disease designation to LM-030, an investigational therapy licensed from …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.